The ocular surface, comprising the cornea, conjunctiva, and associated structures, plays a crucial role in maintaining visual clarity and ocular health. Ocular surface diseases encompass a spectrum of conditions that can compromise the integrity and function of these delicate tissues, leading to discomfort, visual disturbances, and potential vision loss. While many ocular surface diseases can be managed with medical therapy, surgical interventions have emerged as valuable tools in the treatment armamentarium, offering hope for patients with refractory or advanced cases. In this article, we explore the surgical management of ocular surface diseases, highlighting innovations, techniques, and outcomes that underscore the evolving landscape of ocular surface surgery.

Before delving into surgical interventions, it’s essential to recognize some common ocular surface diseases:

• Dry Eye Disease: Characterized by insufficient tear production or poor tear quality, leading to ocular discomfort and visual disturbances.
• Ocular Surface Neoplasia: Including conditions such as conjunctival or corneal intraepithelial neoplasia, which may require surgical excision.
• Pterygium: A non-cancerous growth of conjunctival tissue onto the cornea, often requiring surgical removal.
• Corneal Dystrophies: Inherited disorders affecting corneal clarity and structure, sometimes necessitating corneal transplantation.

1. Limbal Stem Cell Transplantation (LSCT):

• • Indication: LSCT is primarily indicated for patients with limbal stem cell deficiency (LSCD), a condition characterized by the loss or dysfunction of limbal stem cells responsible for regenerating the corneal epithelium.
  • Techniques: LSCT techniques include autologous transplantation, where healthy limbal tissue is harvested from the patient’s unaffected eye, and allogeneic transplantation, where donor tissue is used. Additionally, ex vivo expansion of limbal epithelial cells can be performed in specialized laboratories to generate a sufficient amount of transplantable tissue.
  • Procedure: The transplantation procedure involves the meticulous removal of unhealthy or scarred tissue from the affected eye’s limbal region, followed by the placement of healthy limbal tissue onto the exposed cornea. The transplanted cells then proliferate and regenerate the corneal epithelium, restoring ocular surface integrity and visual function.
  • Outcomes: LSCT has shown promising outcomes in restoring vision and improving ocular comfort in patients with LSCD. Success rates vary depending on factors such as the underlying cause of LSCD, the extent of corneal involvement, and the surgical technique employed.

2. Amniotic Membrane Transplantation (AMT):

• • Indication: AMT is indicated for various ocular surface disorders characterized by epithelial defects, inflammation, or poor wound healing, such as persistent epithelial defects, corneal ulcers, chemical burns, or ocular surface reconstruction following surgical excision of neoplastic lesions.
  • Techniques: AMT can be performed using dehydrated amniotic membrane grafts, cryopreserved amniotic membrane grafts, or freshly harvested amniotic membrane tissue obtained from placental donors.
  • Procedure: During the procedure, the amniotic membrane graft is placed onto the affected area of the ocular surface, where it serves as a biological scaffold to promote epithelialization, reduce inflammation, and modulate wound healing. The membrane gradually dissolves over time, leaving behind a regenerated epithelial layer and improved ocular surface health.
  • Outcomes: AMT has demonstrated efficacy in promoting epithelial healing, reducing inflammation, and improving ocular surface stability in various ocular surface disorders. It is well-tolerated and associated with minimal adverse effects, making it a valuable adjunctive therapy in the management of challenging cases.

3. Conjunctival Reconstruction:

• • Indication: Conjunctival reconstruction techniques are indicated for patients with extensive conjunctival scarring, neoplastic lesions, or severe dry eye disease refractory to conservative treatments.
  • Techniques: Various techniques can be employed for conjunctival reconstruction, including conjunctival autografts, rotational flaps, or amniotic membrane grafting.
  • Procedure: Depending on the specific indication and extent of conjunctival involvement, the surgeon may harvest healthy conjunctival tissue from a donor site on the patient’s eye or use donor tissue obtained from placental sources. The harvested tissue is then transplanted onto the affected area of the conjunctiva to restore ocular surface integrity and improve tear film stability.
  • Outcomes: Conjunctival reconstruction procedures aim to alleviate symptoms of ocular discomfort, improve tear film quality, and promote ocular surface healing in patients with conjunctival scarring or dysfunction. Success rates vary depending on the underlying pathology and the surgical technique employed.

4. Corneal Transplantation:

• • Indication: Corneal transplantation, also known as keratoplasty, is indicated for patients with corneal disease or damage that cannot be adequately managed with conservative measures. Common indications include corneal scarring, keratoconus, corneal dystrophies, corneal endothelial dysfunction, or corneal perforations.
  • Techniques: Different techniques of corneal transplantation are available, including penetrating keratoplasty (PKP), deep anterior lamellar keratoplasty (DALK), Descemet’s stripping automated endothelial keratoplasty (DSAEK), and Descemet’s membrane endothelial keratoplasty (DMEK), each targeting specific layers of the cornea and underlying pathology.
  • Procedure: During corneal transplantation, the diseased or damaged corneal tissue is surgically removed and replaced with healthy donor corneal tissue obtained from a deceased donor. The donor tissue is carefully sutured or positioned onto the recipient’s cornea, where it integrates and restores corneal clarity and function over time.
  • Outcomes: Corneal transplantation is associated with high success rates and can significantly improve visual acuity and quality of life in patients with corneal disease or injury. Advances in surgical techniques, tissue preservation, and postoperative management have contributed to improved outcomes and reduced rejection rates in corneal transplantation procedures.

Surgical management of ocular surface diseases represents a dynamic field characterized by innovation and refinement of techniques aimed at preserving vision and improving patient outcomes. From limbal stem cell transplantation to corneal transplantation, surgical interventions offer hope for patients with challenging ocular surface conditions. As our understanding of ocular surface physiology and surgical techniques continues to evolve, the future holds promise for further advancements in the management of ocular surface diseases, ultimately enhancing the quality of life for patients worldwide.

World Eye Care Foundation’s eyecare.live brings you the latest information from various industry sources and experts in eye health and vision care. Please consult with your eye care provider for more general information and specific eye conditions. We do not provide any medical advice, suggestions or recommendations in any health conditions.